The next leap in cancer care: combining multi-modality and spectral imaging, advanced therapies, robotics and AI to enable standardized, precise interventional oncology treatments for cancer patients
Empowering interventional oncologists to treat with greater precision
Every day, healthcare professionals make decisions that shape a patient’s future and innovation supports them
PreciseOnco elevates interventional oncology (IO) through minimally invasive approaches that respect the patient’s body while maximizing therapeutic impact. With only the smallest incisions, you can offer treatments that reduce trauma and speed recovery.
Driven by next‑generation spectral imaging, PreciseOnco gives you deeper insight into tissue characteristics, clearer visualization, and the confidence to target disease with unmatched accuracy.
Project Objectives
Improve the quality of spectral imaging scans for precise oncological interventions
Optimising the workflow for improved efficiency and precision during spectral-guided IO procedures
Develop new spectral imaging biomarkers for follow-up and treatment success evaluation
Evaluate economical impact and influence relevant stakeholders for technology adoption
Empowering more precise decisions from planning to intervention to follow‑up to deliver the most accurate cancer care at every step.
News and Updates
Clinical Studies
Clinical validation is at the core of PreciseOnco. The project evaluates its imaging, AI, robotic, and workflow innovations through a set of multi‑centre, real‑world clinical studies conducted at leading European hospitals.
PreciseOnco’s clinical studies evaluate how spectral CT and cone‑beam CT, enhanced by AI and robotic assistance, can improve tumour targeting, treatment guidance, and intra‑procedural decision‑making in minimally invasive cancer care.
Covering multiple cancer types and interventional techniques, the studies generate robust, real‑world evidence on clinical benefit, usability, and workflow impact, supporting safe adoption in routine practice
Our Approach at a Glance
PreciseOnco follows an integrated, end‑to‑end approach that combines spectral imaging, artificial intelligence, robotics, and advanced therapies to improve the precision of minimally invasive cancer treatments.
Integrated precision technologies
Combining spectral imaging, AI, and robotic assistance into unified workflows that enable more accurate, reproducible interventional oncology treatments
Clinical validation in real practice
Testing innovations in multi‑centre, real‑world clinical studies across different cancer types and interventional procedures to ensure safety and relevance
From research to patient benefit
Supporting adoption through workflow optimisation and economic evidence, ensuring results translate into standardised, precise, and patient‑centred cancer care
Achievements and Results
Public Reports
Scientific Publications
Media & Resources
Discover the outcomes of our research and development efforts in our public deliverables and reports.
Access our latest research articles and conference papers to stay updated on our progress.
Access a variety of resources, including infographics, videos, and presentations, to learn more about PreciseOnco’s technologies and their applications.
Partners
